To check whether the ABCC4 expression upregulation is related to the TGFβ signaling pathway in CRC, we analyzed GSE18105 datasets—which represent the statistically most significant differences in EMT markers between normal and cancer cells—for the expression of TGFβ1/2 and their receptors. The gene discussed is TGFB1; the disease is cancer.